Aspire Biopharma Holdings Inc. Common Stock (ASBP)
Stock · NASDAQ · Health Care
$8.78as of 10/16/2026
Price chart
Active signals
ASBP Signal Track Record
How signals performed across all stocks →What ASBP's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakout | 23 | +0.2% | 57% | August 31, 2026 |
| Volume Spike | 11 | -4.8% | 27% | October 8, 2026 |
| Bollinger Band Breakdown | 11 | -2.6% | 45% | April 15, 2026 |
| 200-Day Moving Average TouchActive now | 8 | +0.8% | 75% | June 30, 2026 |
| Any 20-session window (baseline) | +0.2% | 54% |
Computed by MarketWall from daily closing prices since January 26, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ASBP
Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects. Its lea…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- www.powerupacq.com/
Fundamentals
- 1-day range
- $7.19$8.45
- Market cap
- $9.14M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-121.90
- Dividend yield
- —
- Beta
- 0.20
- Avg. volume
- 37.3K
How Aspire Biopharma Holdings Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 30, 2026 · via SEC EDGAR / Finnhub
Aspire Biopharma Holdings Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ASBPAspire Biopharma Holdings Inc. Common Stock$8.78▲ 1.62%Market cap $9.14MP/E —$3.31$562.8
- QNRXQuoin Pharmaceuticals Ltd. American Depositary Shares$3.9▼ 3.23%Market cap $9.18MP/E —$3.25$23.5
- IMRNImmuron Limited American Depositary Shares$0.982▼ 4.66%Market cap $8.88MP/E —$0.026$0.098
- LEXXLexaria Bioscience Corp. Common Stock$2.86▼ 4.35%Market cap $8.82MP/E —$2.43$21.6
- GDTCCytoMed Therapeutics Limited Ordinary Shares$0.88▲ 1.15%Market cap $9.50MP/E —$0.6801$3.68
- XCURExicure Inc. Common Stock$1.12▲ 0.00%Market cap $8.60MP/E —$0.936$9.48
- LSTALisata Therapeutics Inc. Common Stock$1.03▼ 3.74%Market cap $9.74MP/E —$0.98$5.07
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ASBP Aspire Biopharma Holdings Inc. Common Stock | $9.14M | — | $8.78 | ▲ 1.62% | $3.31$562.8 |
| QNRX Quoin Pharmaceuticals Ltd. American Depositary Shares | $9.18M | — | $3.9 | ▼ 3.23% | $3.25$23.5 |
| IMRN Immuron Limited American Depositary Shares | $8.88M | — | $0.982 | ▼ 4.66% | $0.026$0.098 |
| LEXX Lexaria Bioscience Corp. Common Stock | $8.82M | — | $2.86 | ▼ 4.35% | $2.43$21.6 |
| GDTC CytoMed Therapeutics Limited Ordinary Shares | $9.50M | — | $0.88 | ▲ 1.15% | $0.6801$3.68 |
| XCUR Exicure Inc. Common Stock | $8.60M | — | $1.12 | ▲ 0.00% | $0.936$9.48 |
| LSTA Lisata Therapeutics Inc. Common Stock | $9.74M | — | $1.03 | ▼ 3.74% | $0.98$5.07 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.